The World Health Organization explains that RRP affects four out of every 100,000 children and 1-2 out of every 100,000 adults globally. [iStockphoto] In the bustling corridors of Kenyatta National ...
The recent safety review of two approved RSV preventive treatments for infants initiated by the U.S. Food and Drug ...
Pediatric Investigation published a guideline with 24 key recommendations to improve diagnosis, treatment, and follow-up in juvenile-onset recurrent respiratory papillomatosis in the Chinese context.
Please provide your email address to receive an email when new articles are posted on . The FDA approved the adenoviral vector-based immunotherapy, zopapogene imadenovec-drba, for treatment of certain ...
– Recurrent respiratory papillomatosis is a rare, debilitating, chronic disease that impacts both children and adults and is mainly driven by HPV 6/11 infection – – There is no FDA-approved ...
Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the respiratory virus season. However, especially among young infants under six ...
A remarkable recent increase in the diagnosis of vocal-cord cancer in young adults appears to be the result of infection with strains of human papilloma virus that also cause cervical cancer and other ...
A mild cold, sore throat, and changes in appetite are common signs of RSV in children. In some cases, symptoms may be more severe. Respiratory tract infections (RTIs) happen when an infection develops ...
Despite a relatively slow start to respiratory disease season, low vaccination rates threaten that trend and the rapid rise of some illnesses is already putting children at increased risk. Overall, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback